Trademarkia Logo

Canada

C$
DEVRIAZ
REGISTERED

on 20 Jun 2019

Last Applicant/ Owned by

PFIZER PRODUCTS INC.

Eastern Point RoadGroton, CT 06340

US

Serial Number

1682635 filed on 25th Jun 2014

Registration Number

TMA1029718 registered on 20th Jun 2019

Registration expiry Date

20th Jun 2029

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

DEVRIAZ

Trademark usage description

pharmaceutical preparations for the treatment of cardiovascular disease, gastrointestinal diseases and disorders, allergies, diabetes, hypertension, e Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cardiovascular disease, gastrointestinal diseases and disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, hemolytic diseases and disorders, cancer, migraines, obesity, respiratory system diseases and disorders; carpal tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, multiple sclerosis, yeast infections, prostate disorders, pulmonary disorders, macular degeneration, fibromyalgia, stroke; Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, muscular dystrophy, sickle cell disease, and anemia; Pharmaceutical preparations for the prevention and treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Huntington's disease, cerebral palsy, multiple sclerosis; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of genitourinary diseases and disorders, namely urological diseases, urinary incontinence, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation; Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the prevention and treatment of pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia; chronic pain; Pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the prevention and treatment of infectious diseases, namely respiratory infections, eye infections; Pharmaceutical preparations for the prevention and treatment of immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for the prevention and treatment of viral diseases and disorders, namely herpes, hepatitis; Pharmaceutical preparations for the prevention and treatment of HIV, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for the prevention and treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression; Pharmaceutical preparations for the prevention and treatment of substance abuse disorders, namely alcoholism and drug addiction; Pharmaceutical preparations for the prevention and treatment of sleep disorders, namely, insomnia and restless leg syndrome; (2) Pharmaceutical preparations for use in oncology, ophthalmology, ocular disorders, gastroenterology, and gynecology; Pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases; (3) Pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; tissue and skin repair preparations; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; antiemetics; antiflatulants; antihistamines; anti-infectives; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives.


Classification kind code

10

Mark Details


Serial Number

1682635

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 51
on 29th Jul 2016
Allowance Notice Sent
Submitted for opposition 42
on 13th Apr 2016
Advertised
Submitted for opposition 26
on 24th Mar 2016
Approved
Submitted for opposition 27
on 3rd Feb 2016
Approval Notice Sent
Submitted for opposition 15
on 14th May 2015
Correspondence Created
Submitted for opposition 22
on 31st Dec 2014
Search Recorded
Submitted for opposition 20
on 31st Dec 2014
Examiner's First Report
Submitted for opposition 31
on 26th Jun 2014
Formalized
Submitted for opposition 30
on 25th Jun 2014
Filed
Submitted for opposition 1
on 25th Jun 2014
Created